Neurovascular neuro-ophthalmology: with 61 tables
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Berlin u.a.
Springer
1993
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturverz. S. 467 - 540 |
| Beschreibung: | XVIII, 554 S. Ill., graph. Darst. |
| ISBN: | 3540556362 0387556362 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV005866689 | ||
| 003 | DE-604 | ||
| 005 | 20240109 | ||
| 007 | t| | ||
| 008 | 921109s1993 gw ad|| |||| 00||| eng d | ||
| 020 | |a 3540556362 |9 3-540-55636-2 | ||
| 020 | |a 0387556362 |9 0-387-55636-2 | ||
| 035 | |a (OCoLC)231403416 | ||
| 035 | |a (DE-599)BVBBV005866689 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-12 |a DE-355 |a DE-29 |a DE-188 | ||
| 084 | |a YO 9000 |0 (DE-625)153965:12905 |2 rvk | ||
| 084 | |a WW 460 |2 nlm | ||
| 100 | 1 | |a Kupersmith, Mark J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Neurovascular neuro-ophthalmology |b with 61 tables |c M. J. Kupersmith. In collab. with A. Berenstein |
| 264 | 1 | |a Berlin u.a. |b Springer |c 1993 | |
| 300 | |a XVIII, 554 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturverz. S. 467 - 540 | ||
| 650 | 0 | 7 | |a Durchblutungsstörung |0 (DE-588)4013340-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gefäßkrankheit |0 (DE-588)4071631-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neuroophthalmologie |0 (DE-588)4171592-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Augenkrankheit |0 (DE-588)4112627-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sehstörung |0 (DE-588)4054284-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Neuroophthalmologie |0 (DE-588)4171592-5 |D s |
| 689 | 0 | 1 | |a Gefäßkrankheit |0 (DE-588)4071631-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Neuroophthalmologie |0 (DE-588)4171592-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Sehstörung |0 (DE-588)4054284-1 |D s |
| 689 | 2 | 1 | |a Durchblutungsstörung |0 (DE-588)4013340-0 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Sehstörung |0 (DE-588)4054284-1 |D s |
| 689 | 3 | 1 | |a Gefäßkrankheit |0 (DE-588)4071631-4 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Augenkrankheit |0 (DE-588)4112627-0 |D s |
| 689 | 4 | 1 | |a Gefäßkrankheit |0 (DE-588)4071631-4 |D s |
| 689 | 4 | |5 DE-604 | |
| 700 | 1 | |a Berenstein, Alex |d 1947- |e Verfasser |0 (DE-588)111120713 |4 aut | |
| 856 | 4 | 2 | |m SWB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003673643&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-003673643 | |
Datensatz im Suchindex
| _version_ | 1820875795713753088 |
|---|---|
| adam_text |
IMAGE 1
CONTENTS
CHAPTER 1 CIRCULATION OF THE EYE, ORBIT, CRANIAL NERVES, AND BRAIN
1.1 INTRODUCTION 1
1.2 CAROTID ARTERIAL SYSTEM 1
1.2.1 COMMON CAROTID ARTERY 1
1.2.2 EXTERNAL CAROTID ARTERIAL SYSTEM 1
1.2.3 INTERNAL CAROTID ARTERY SYSTEM 2
1.2.4 CEREBRAL ARTERIES 5
1.3 VERTEBROBASILAR ARTERIAL SYSTEM 5
1.3.1 VERTEBRAL AND BASILAR ARTERIES 5
1.3.2 POSTERIOR CEREBRAL ARTERY 5
1.4 INTRACRANIAL VENOUS DRAINAGE 8
1.4.1 SUPRATENTORIAL DEEP AND SUPERFICIAL VENOUS SYSTEMS 10 1.4.2 VENOUS
DRAINAGE OF THE POSTERIOR FOSSA 10
1.5 CIRCULATION IN REGIONS OF NEURO-OPHTHALMOLOGIC IMPORTANCE . . . 13
1.5.1 ORBITAL CIRCULATION 13
1.5.2 SENSORY VISUAL PATHWAY CIRCULATION 19
1.5.3 EFFERENT PATHWAY CIRCULATION 50
1.6 CEREBRAL BLOOD FLOW PHYSIOLOGY 66
CHAPTER 2
CAROTID CAVERNOUS FISTULAS
2.1 EPIDEMIOLOGY AND CAUSES 69
2.1.1 TRAUMA 69
2.1.2 SPONTANEOUS CAROTID CAVERNOUS FISTULAS 70
2.2 CLINICAL PRESENTATION, EVALUATION, AND DIFFERENTIAL DIAGNOSIS . . .
72 2.2.1 SYMPTOMS AND SIGNS 72
2.2.2 RED EYE DIFFERENTIAL DIAGNOSIS 75
2.2.3 VENOUS ISCHEMIC-HYPOXIC RETINOPATHY: DIFFERENTIAL DIAGNOSIS 76
2.2.4 ORBITAL BRUIT DIFFERENTIAL DIAGNOSIS 76
2.3 LABORATORY EVALUATION 77
2.3.1 ULTRASONOGRAPHY 77
2.3.2 COMPUTED TOMOGRAPHY 77
2.3.3 MAGNETIC RESONANCE IMAGING 79
2.3.4 ANGIOGRAPHY 79
2.4 THERAPY 95
2.4.1 VISUAL LOSS, CRANIAL NEUROPATHY 95
IMAGE 2
X CONTENTS
2.4.2 GLAUCOMA 95
2.4.3 CORNEAL ABNORMALITIES 96
2.4.4 MANUAL COPRESSION OF THE INTERNAL CAROTID ARTERY 96
2.4.5 EMERGENCY TREATMENT 96
2.4.6 SURGERY 97
2.4.7 EMBOLIZATION 99
2.4.8 MANAGEMENT OF ASSOCIATED INJURIES 104
2.4.9 RESULTS AND COMPLICATIONS 104
2.4.10 THERAPY IS NOT ALWAYS WARRANTED 108
CHAPTER 3
NEURO-OPHTHALMIC MANIFESTATIONS OF INTRACRANIAL DURAL VENOUS DISORDERS
3.1 INTRODUCTION 109
3.2 DURAL ARTERIOVENOUS MALFORMATIONS AND SHUNTS 109
3.2.1 EPIDEMIOLOGY 109
3.2.2 CLINICAL FEATURES I LL
3.2.3 MECHANISMS OF DYSFUNCTION OF DURAL ARTERIOVENOUS MALFORMATIONS 117
3.2.4 PATHOLOGY AND ETIOLOGY 122
3.2.5 NEUROIMAGING 122
3.2.6 THERAPY AND COURSE 123
3.2.7 DURAL ARTERIOVENOUS MALFORMATION OF THE CAVERNOUS SINUS AREA 125
3.3 DURAL VENOUS SINUS THROMBOSIS 141
3.3.1 INTRODUCTION 141
3.3.2 CAVERNOUS SINUS THROMBOSIS 142
3.3.3 SUPERIOR SAGITTAL SINUS THROMBOSIS 145
3.3.4 LATERAL SINUS THROMBOSIS 147
3.3.5 THROMBOSIS IN OTHER DURAL SINUSES 148
3.3.6 MECHANICAL OCCLUSION OF THE DURAL VENOUS SINUSES 148
CHAPTER 4
ORBITAL VASCULAR LESIONS
4.1 INTRODUCTION 151
4.2 CLINICAL EVALUATION OF PATIENTS WITH ORBITAL DISEASE 151
4.3 IMAGING OF ORBITAL LESIONS 154
4.3.1 COMPUTED TOMOGRAPHY 154
4.3.2 MAGNETIC RESONANCE IMAGING 154
4.3.3 ULTRASONOGRAPHY 155
4.3.4 ANGIOGRAPHY 155
4.3.5 VENOGRAPHY 155
4.4 ORBITAL VARIX 156
4.4.1 CLINICAL MANIFESTATIONS 156
4.4.2 HISTOPATHOLOGY 157
IMAGE 3
CONTENTS XI
4.4.3 IMAGING 157
4.4.4 COURSE AND TREATMENT 159
4.5 ARTERIOVENOUS MALFORMATION 161
4.5.1 CLINICAL MANIFESTATIONS 161
4.5.2 HISTOPATHOLOGY 162
4.5.3 IMAGING 163
4.5.4 TREATMENT 163
4.6 CAPILLARY HEMANGIOMA 165
4.6.1 CLINICAL MANIFESTATIONS 165
4.6.2 HISTOPATHOLOGY 166
4.6.3 IMAGING 166
4.6.4 TREATMENT 167
4.7 CAVERNOUS HEMANGIOMA (CAVERNOMA) 168
4.7.1 CLINICAL MANIFESTATIONS 168
4.7.2 HISTOPATHOLOGY 168
4.7.3 IMAGING 169
4.7.4 TREATMENT 170
4.8 LYMPHANGIOMA 171
4.8.1 CLINICAL MANIFESTATIONS 171
4.8.2 HISTOPATHOLOGY 173
4.8.3 IMAGING 173
4.8.4 TREATMENT 175
4.9 HEMANGIOPERICYTOMA 175
4.9.1 CLINICAL MANIFESTATIONS 175
4.9.2 HISTOPATHOLOGY 175
4.9.3 IMAGING 175
4.9.4 TREATMENT 176
4.10 MALIGNANT HEMANGIOENDOTHELIOMA 176
4.10.1 CLINICAL MANIFESTATIONS 176
4.10.2 HISTOPATHOLOGY 177
4.10.3 IMAGING 177
4.10.4 TREATMENT 177
4.11 LEIOMYOMA 177
4.11.1 CLINICAL MANIFESTATIONS 177
4.11.2 HISTOPATHOLOGY 177
4.11.3 IMAGING 177
4.11.4 TREATMENT 177
4.12 VASCULAR TUMORS OF THE SPHENOID WING AND THE CAVERNOUS SINUS 178
4.12.1 MENINGIOMA 178
4.12.2 FIBROUS DYSPLASIA 179
4.12.3 HEMANGIOPERICYTOMA 183
4.13 VASCULAR PHAKOMATOSES (NEUROCUTANEOUS SYNDROMES) 183 4.13.1
STURGE-WEBER SYNDROME (ENCEPHALOTRIGEMINAL ANGIOMATOSIS) 183
4.13.2 VON HIPPEL-LINDAU DISEASE (RETINOCEREBELLAR ANGIOMATOSIS) 188
4.13.3 WYBURN-MASON SYNDROME 192
4.13.4 KLIPPEL-TRENAUNAY-WEBER SYNDROME 195
IMAGE 4
XII CONTENTS
4.13.5 OSLER-WEBER-RENDU SYNDROME (HEREDITARY HEMORRHAGIC
TELANGIECTASIA) 195
4.14 CAVERNOUS HEMANGIOMA OF THE BRAIN AND RETINA 196
CHAPTER 5
VASCULAR OPTIC NEUROPATHIES
5.1 ANTERIOR ISCHEMIC OPTIC NEUROPATHY 197
5.1.1 CLINICAL PRESENTATION 197
5.1.2 CLINICAL COURSE 200
5.1.3 RISK FACTORS 203
5.1.4 CATARACT SURGERY 203
5.1.5 EMBOLI 204
5.1.6 DIFFERENTIAL DIAGNOSIS OF UNILATERAL VISUAL LOSS AND OPTIC DISC
SWELLING 205
5.1.7 PATHOLOGY AND LOCALIZATION OF THE ISCHEMIC PROCESS . . . 206
5.1.8 LABORATORY AND SYSTEMIC DISEASE EVALUATION 206
5.1.9 TREATMENT 208
5.2 GIANT-CELL ARTERITIS 208
5.2.1 CLINICAL PRESENTATION 209
5.2.2 CLINICAL EXAMINATION 210
5.2.3 LABORATORY EVALUATION 212
5.2.4 TEMPORAL ARTERY BIOPSY 213
5.2.5 PATHOPHYSIOLOGY 215
5.2.6 OCULAR PATHOLOGY 215
5.2.7 TREATMENT AND COURSE 216
5.3 PAPILLEDEMA 218
5.3.1 OPHTHALMOLOGIC FINDINGS 219
5.3.2 MECHANISMS OF VISUAL DISTURBANCE 222
5.4 LEBER'S OPTIC NEUROPATHY 222
5.4.1 MOLECULAR ASPECTS 222
5.4.2 CARDIAC AND NEUROLOGIC ABNORMALITIES 222
5.4.3 OPHTHALMOLOGIC FINDINGS AND CLINICAL COURSE 222
5.4.4 TREATMENT 224
5.5 POSTSHOCK OPTIC NEUROPATHY 224
5.5.1 CAUSES 224
5.5.2 OPHTHALMOLOGIC FINDINGS 224
5.6 LOW-TENSION GLAUCOMA 225
5.6.1 OPHTHALMOLOGIC FINDINGS 225
5.6.2 PATHOGENESIS 227
5.6.3 DIFFERENTIAL DIAGNOSIS 227
5.6.4 TREATMENT AND COURSE 228
5.7 JUVENILE DIABETES MELLITUS 229
5.8 OPTIC DISC VASCULITES OR PAPILLOPHLEBITIS 229
5.8.1 DIFFERENTIAL DIAGNOSIS 230
5.8.2 PATHOLOGY 232
5.8.3 DIAGNOSTIC EVALUATION 232
5.8.4 TREATMENT 232
IMAGE 5
CONTENTS XIII
5.9 POSTERIOR ISCHEMIC OPTIC NEUROPATHY 232
5.10 RARE CAUSES OF ISCHEMIC OPTIC NEUROPATHY 233
5.11 RADIATION DAMAGE TO THE EYE AND BRAIN 233
5.11.1 INTRODUCTION 233
5.11.2 RADIATION RETINOPATHY 234
5.11.3 RADIATION OPTIC NERVE AND CHIASM NEUROPATHY 235 5.11.4
RETROCHIASMAL RADIATION DAMAGE 236
5.11.5 ARTERIAL OCCLUSIVE DISEASE 237
5.11.6 NONVASCULAR COMPLICATIONS 237
5.11.7 TREATMENT 238
CHAPTER 6
ANEURYSMS INVOLVING THE MOTOR AND SENSORY VISUAL PATHWAYS
6.1 GENERAL DISCUSSION 239
6.1.1 INTRODUCTION 239
6.1.2 INCIDENCE 239
6.1.3 ETIOLOGY 240
6.1.4 RUPTURE 240
6.1.5 REBLEED 242
6.1.6 MORBIDITY AND MORTALITY 242
6.1.7 NEURO-OPHTHALMOLOGIC SYMPTOMS AND SIGNS 242
6.1.8 NEUROIMAGING 245
6.1.9 CEREBROSPINAL FLUID 250
6.1.10 THERAPY AND COURSE 250
6.2 CAROTID CAVERNOUS ANEURYSM 254
6.2.1 INCIDENCE AND DIFFERENTIAL DIAGNOSIS 254
6.2.2 CLINICAL PRESENTATION AND NEURO-OPTHALMOLOGIC DYSFUNCTION 254
6.2.3 DIFFERENTIAL DIAGNOSIS OF PAINFUL OPHTHALMOPLEGIA 257 6.2.4
NEUROIMAGING 258
6.2.5 TREATMENT AND COURSE 260
6.3 POSTERIOR COMMUNICATING ARTERY ANEURYSM 265
6.3.1 INCIDENCE 265
6.3.2 CLINICAL PRESENTATION 265
6.3.3 NEUROIMAGING 268
6.3.4 THERAPY AND OUTCOME 270
6.4 CAROTID-OPHTHALMIC ARTERY ANEURYSM 272
6.4.1 INCIDENCE 272
6.4.2 CLINICAL PRESENTATION 272
6.4.3 NEUROIMAGING 281
6.4.4 TREATMENT AND COURSE 282
6.5 ANEURYSM OF THE INTERNAL CAROTID ARTERY BIFURCATION 283
6.5.1 INCIDENCE 283
6.5.2 CLINICAL PRESENTATION 283
6.5.3 NEUROIMAGING 283
6.5.4 TREATMENT AND COURSE 286
6.6 ANTERIOR COMMUNICATING ARTERY ANEURYSM 288
IMAGE 6
XIV CONTENTS
6.6.1 INCIDENCE 288
6.6.2 CLINICAL PRESENTATION 288
6.6.3 NEUROIMAGING 288
6.6.4 THERAPY AND OUTCOME 288
6.7 BASILAR ARTERY ANEURYSM 290
6.7.1 INCIDENCE 290
6.7.2 CLINICAL PRESENTATION 290
6.7.3 NEUROIMAGING 291
6.7.4 TREATMENT AND COURSE 291
6.8 OTHER POSTERIOR CIRCULATION ANEURYSMS 294
6.9 NONSACCULAR ANEURYSMS 295
6.9.1 FUSIFORM ANEURYSMS 295
6.9.2 TRAUMATIC ANEURYSMS 296
6.9.3 MYCOTIC ANEURYSMS 297
CHAPTER 7
VASCULAR MALFORMATIONS OF THE BRAIN
7.1 ARTERIOVENOUS MALFORMATIONS 301
7.1.1 INTRODUCTION 301
7.1.2 INCIDENCE 301
7.1.3 PRESENTATION 303
7.1.4 HEMODYNAMICS: CONTROVERSIES AND UNRESOLVED QUESTIONS . 307 7.1.5
HEMODYNAMICS: CLINICAL FEATURES 315
7.1.6 POSTERIOR FOSSA BRAIN ARTERIOVENOUS MALFORMATIONS: SPECIAL
CIRCUMSTANCES 325
7.1.7 VEIN OF GALEN MALFORMATIONS 331
7.1.8 LONG-TERM FOLLOW-UP OF BRAIN ARTERIOVENOUS MALFORMATIONS 331
7.1.9 RADIOGRAPHIC EVALUATION 333
7.1.10 SPECIFIC VISUAL SENSORY OR OCULAR MOTOR ABNORMALITIES RELATED TO
BRAIN ARTERIOVENOUS MALFORMATIONS 336
7.1.11 TREATMENT 341
7.2 OTHER VASCULAR LESIONS OF THE BRAIN 345
7.2.1 TELANGIECTASIA 345
7.2.2 CAVERNOMA (CAVERNOUS HEMANGIOMA) 346
7.2.3 VENOUS VASCULAR ANOMALIES (VENOUS ANGIOMA) 349
CHAPTER 8
EMBOLIC AND NONINFLAMMATORY OCCLUSIVE VASCULAR DISEASE OF THE VISUAL AND
OCULAR MOTOR SYSTEMS
8.1 INTRODUCTION 353
8.2 OCULAR ISCHEMIA 353
8.2.1 INTRAOCULAR ISCHEMIC ALTERATIONS 353
8.2.2 OTHER SIGNS OF OCULAR ISCHEMIA 356
8.2.3 EMBOLIC OCULAR DISEASE 356
IMAGE 7
CONTENTS XV
8.2.4 RELATIONSHIP OF OCULAR ISCHEMIC EVENTS TO CAROTID AND CARDIAC
DISEASE 364
8.2.5 SYNDROME OF ISCHEMIC OCULOPATHY 366
.3 CAROTID AND CARDIAC EVALUATION .* 368
8.3.1 BRUIT 368
8.3.2 OPHTHALMODYNAMOMETRY 369
8.3.3 OCULAR PNEUMOPLETHYSMOGRAPHY 369
8.3.4 CAROTID ULTRASONOGRAPHY AND THERMOGRAPHY 369
8.3.5 ANGIOGRAPHY 370
8.3.6 CARDIAC EVALUATION 370
8.3.7 DIFFERENTIAL DIAGNOSIS OF CEREBROVASCULAR OCCLUSIVE DISEASE 371
*A AORTIC ARCH OCCLUSIVE DISEASE 371
1.5 NEURO-OPHTHALMOLOGIC DISORDERS CAUSED BY BRAIN INFARCTS 371 8.5.1
SENSORY VISUAL DISTURBANCES 371
8.5.2 EFFERENT PATHWAY DISTURBANCES 378
1.6 THERAPEUTIC CONSIDERATIONS 386
8.6.1 CARDIAC DISEASE 386
8.6.2 CAROTID ATHEROSCLEROSIS 387
8.6.3 ANTIPLATELET AGENTS 387
8.6.4 ANTICOAGULATION 387
8.6.5 SURGERY 388
8.6.6 ANTIHYPERTENSIVES 390
8.6.7 POSTERIOR CIRCULATION 390
8.6.8 TREATMENT OF OCULAR ISCHEMIC CONDITIONS 390
:.7 ATYPICAL OCCLUSIVE DISEASE OF THE OPHTHALMIC ARTERY 391
1.8 ISCHEMIC CRANIAL NERVE SYNDROMES 391
8.8.1 INTRODUCTION 391
8.8.2 THIRD CRANIAL NERVE VASCULAR NEUROPATHY 392
8.8.3 SIXTH CRANIAL NERVE VASCULAR NEUROPATHY 394
8.8.4 FOURTH CRANIAL NERVE VASCULAR NEUROPATHY 395
8.8.5 ISCHEMIA OF MULTIPLE CRANIAL NERVES 397
1.9 FIBROMUSCULAR DYSPLASIA 397
1.10 MOYAMOYA DISEASE 397
I.L 1 HYPERCOAGULATION DISORDERS 400
8.11.1 SYSTEMIC MALIGNANCY 400
8.11.2 PRIMARY COAGULATION SYSTEM DEFICIENCIES 400
8.11.3 CEREBRAL VENOUS THROMBOSIS 401
1.12 DISSECTION OF THE CAROTID AND VERTEBRAL ARTERIES 401
8.12.1 TRAUMATIC DISSECTION OF THE CERVICAL CAROTID ARTERY . . . 401
8.12.2 SPONTANEOUS DISSECTION OF THE INTERNAL CAROTID ARTERY . 402
8.12.3 DISSECTION OF THE VERTEBRAL ARTERY 405
1.13 METABOLIC DISORDERS ASSOCIATED WITH CEREBRAL VASO-OCCLUSIVE DISEASE
405
8.13.1 HOMOCYSTINURIA 405
8.13.2 MELAS SYNDROME 405
8.13.3 FABRY'S DISEASE 405
1.14 SPECIFIC RETINAL DISORDERS 406
8.14.1 ARTERIOLAR AND CAPILLARY OCCLUSIVE DISEASE 406
8.14.2 VENOUS DISEASE 410
IMAGE 8
XVI CONTENTS
CHAPTER 9
INFLAMMATORY VASCULAR DISORDERS OF THE BRAIN AND EYE
9.1 INTRODUCTION 413
9.2 GIANT CELL ARTERITIS (TEMPORAL ARTERITIS) 414
9.3 POLYARTERITIS NODOSA 414
9.3.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 414
9.3.2 NEUROLOGIC MANIFESTATIONS 415
9.3.3 OPHTHALMOLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS 415 9.3.4
NEUROIMAGING 415
9.3.5 PATHOLOGY 417
9.3.6 LABORATORY EVALUATION 417
9.3.7 TREATMENT AND COURSE 417
9.4 SYSTEMIC LUPUS ERYTHEMATOSUS 417
9.4.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 417
9.4.2 NEUROLOGIC MANIFESTATIONS 418
9.4.3 OPHTHALMOLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS 418 9.4.4
NEUROIMAGING 420
9.4.5 PATHOLOGY 420
9.4.6 LABORATORY EVALUATION 421
9.4.7 TREATMENT AND COURSE 421
9.5 RHEUMATOID ARTHRITIS 422
9.5.1 INCIDENCE 422
9.5.2 NEUROLOGIC MANIFESTATIONS 422
9.5.3 OPHTHALMOLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS 422 9.5.4
LABORATORY EVALUATION 422
9.5.5 TREATMENT 423
9.6 WEGENER'S GRANULOMATOSIS 423
9.6.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 423
9.6.2 NEUROLOGIC MANIFESTATIONS 423
9.6.3 OPHTHALMOLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS 423 9.6.4
LABORATORY EVALUATION AND PATHOLOGY 424
9.6.5 TREATMENT AND COURSE 424
9.7 BEHCET'S SYNDROME 425
9.7.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 425
9.7.2 NEUROLOGIC MANIFESTATIONS 425
9.7.3 OPHTHALMOLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS 425 9.7.4
LABORATORY EVALUATION AND NEUROIMAGING 426
9.7.5 TREATMENT AND COURSE 426
9.8 GRANULOMATOUS ANGIITIS CONFINED TO THE CENTRAL NERVOUS SYSTEM 426
9.8.1 NEUROLOGIC MANIFESTATIONS 426
9.8.2 DIFFERENTIAL DIAGNOSIS 428
9.8.3 NEUROIMAGING 428
9.8.4 PATHOLOGY 428
9.8.5 LABORATORY EVALUATION 428
9.8.6 TREATMENT AND COURSE 428
9.9 CENTRAL NERVOUS SYSTEM ANGIITIS OF OTHER CAUSES 428
9.9.1 HERPES ZOSTER 428
IMAGE 9
CONTENTS XVII
9.9.2 RELAPSING POLYCHONDRITIS 430
9.9.3 ALLERGIC GRANULOMATOUS ANGIITIS (CHURG-STRAUSS SYNDROME) 430
9.9.4 SUBSTANCE ABUSE 430
9.10 TAKAYASU'S ARTERITIS 431
9.10.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 431
9.10.2 NEUROLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS . 431 9.10.3
IMAGING 431
9.10.4 PATHOLOGY 431
9.10.5 LABORATORY EVALUATION 431
9.10.6 TREATMENT 432
9.11 COGAN'S SYNDROME 432
9.11.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 432
9.11.2 NEUROLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS . 432 9.11.3
TREATMENT 432
9.12 LYMPHATOID GRANULOMATOSIS 433
9.12.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 433
9.12.2 NEUROLOGIC AND NEURO-OPHTHALMOLOGIC MANIFESTATIONS . 433 9.12.3
LABORATORY EVALUATION AND PATHOLOGY 433
9.12.4 TREATMENT 433
9.13 MICROANGIOPATHY OF THE RETINA AND BRAIN 433
9.13.1 OPHTHALMOLOGIC AND NEUROLOGIC MANIFESTATIONS 433 9.13.2
DIFFERENTIAL DIAGNOSIS 434
9.13.3 LABORATORY EVALUATION 435
9.13.4 TREATMENT 435
9.14 EALES , DISEASE (PERIPHLEBITIS RETINAE) 435
9.15 ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY AND
CEREBRAL VASCULITIES 436
9.15.1 TREATMENT AND COURSE 437
9.16 SJOGREN'S SYNDROME 437
9.16.1 INCIDENCE AND SYSTEMIC INVOLVEMENT 437
9.16.2 NEUROLOGIC MANIFESTATIONS 437
9.16.3 NEURO-OPHTHALMOLOGIC MANIFESTATIONS 438
9.16.4 LABORATORY EVALUATION 438
9.16.5 NEUROIMAGING 438
9.16.6 TREATMENT 438
9.17 OCCLUSIVE DISEASE ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODY
SYNDROMES: A DISORDER IN EVOLUTION 438
9.17.1 TREATMENT 439
CHAPTER 10
MIGRAINE
10.1 INTRODUCTION AND EPIDEMIOLOGY 441
10.2 TYPES OF MIGRAINE 441
10.2.1 CLASSIC MIGRAINE 441
10.2.2 COMMON MIGRAINE 441
10.2.3 POSITIVE VISUAL DISTURBANCES IN CLASSIC AND COMMON MIGRAINE 443
IMAGE 10
XVIII CONTENTS
10.2.4 COMPLICATED MIGRAINE 444
10.2.5 OPHTHALMOPLEGIC MIGRAINE 445
10.2.6 ACEPHALGIC MIGRAINE 445
10.2.7 OTHER HEADACHES WITH POSSIBLE VASCULAR DYSFUNCTION . . 446 10.3
THEORIES OF THE CAUSES OF MIGRAINE 446
10.3.1 NEUROTRANSMITTER MAINTENANCE AND ALTERED VASOMOTOR TONE 447
10.3.2 NEURONAL DYSFUNCTION 448
10.3.3 SPREADING DEPRESSION 449
10.3.4 PLATELET HYPERAGGREGABILITY 450
10.3.5 HORMONAL INFLUENCES 450
10.3.6 PSYCHOLOGICAL FACTORS 451
10.3.7 BLOOD-BRAIN BARRIER ALTERATION AND DIETARY FACTORS . . . 451
10.3.8 ALLERGY 451
10.3.9 TRAUMA 452
10.4 THEORIES OF VISUAL AND NEUROLOGIC PHENOMENA 452
10.4.1 POSITIVE PHENOMENA 452
10.4.2 NEGATIVE PHENOMENA 452
10.4.3 PERMANENT NEUROLOGIC OR VISUAL DEFECTS 453
10.5 MECHANISMS OF HEADACHE 457
10.6 LABORATORY EVALUATION 458
10.7 TREATMENT 458
10.7.1 ACUTE EPISODIC HEADACHE MANAGEMENT 458
10.7.2 PROPHYLAXIS 462
10.7.3 FORMERLY USED AGENTS 465
10.7.4 COMPLICATED MIGRAINE TREATMENT 465
REFERENCES 467
SUBJECT INDEX 541 |
| any_adam_object | 1 |
| author | Kupersmith, Mark J. Berenstein, Alex 1947- |
| author_GND | (DE-588)111120713 |
| author_facet | Kupersmith, Mark J. Berenstein, Alex 1947- |
| author_role | aut aut |
| author_sort | Kupersmith, Mark J. |
| author_variant | m j k mj mjk a b ab |
| building | Verbundindex |
| bvnumber | BV005866689 |
| classification_rvk | YO 9000 |
| ctrlnum | (OCoLC)231403416 (DE-599)BVBBV005866689 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV005866689</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240109</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">921109s1993 gw ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540556362</subfield><subfield code="9">3-540-55636-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0387556362</subfield><subfield code="9">0-387-55636-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231403416</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005866689</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YO 9000</subfield><subfield code="0">(DE-625)153965:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WW 460</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kupersmith, Mark J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neurovascular neuro-ophthalmology</subfield><subfield code="b">with 61 tables</subfield><subfield code="c">M. J. Kupersmith. In collab. with A. Berenstein</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin u.a.</subfield><subfield code="b">Springer</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 554 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 467 - 540</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Durchblutungsstörung</subfield><subfield code="0">(DE-588)4013340-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gefäßkrankheit</subfield><subfield code="0">(DE-588)4071631-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neuroophthalmologie</subfield><subfield code="0">(DE-588)4171592-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Augenkrankheit</subfield><subfield code="0">(DE-588)4112627-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sehstörung</subfield><subfield code="0">(DE-588)4054284-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Neuroophthalmologie</subfield><subfield code="0">(DE-588)4171592-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gefäßkrankheit</subfield><subfield code="0">(DE-588)4071631-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Neuroophthalmologie</subfield><subfield code="0">(DE-588)4171592-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Sehstörung</subfield><subfield code="0">(DE-588)4054284-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Durchblutungsstörung</subfield><subfield code="0">(DE-588)4013340-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Sehstörung</subfield><subfield code="0">(DE-588)4054284-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Gefäßkrankheit</subfield><subfield code="0">(DE-588)4071631-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Augenkrankheit</subfield><subfield code="0">(DE-588)4112627-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Gefäßkrankheit</subfield><subfield code="0">(DE-588)4071631-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berenstein, Alex</subfield><subfield code="d">1947-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)111120713</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">SWB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003673643&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003673643</subfield></datafield></record></collection> |
| id | DE-604.BV005866689 |
| illustrated | Illustrated |
| indexdate | 2025-01-10T15:21:19Z |
| institution | BVB |
| isbn | 3540556362 0387556362 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003673643 |
| oclc_num | 231403416 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-29 DE-188 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-29 DE-188 |
| physical | XVIII, 554 S. Ill., graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Springer |
| record_format | marc |
| spelling | Kupersmith, Mark J. Verfasser aut Neurovascular neuro-ophthalmology with 61 tables M. J. Kupersmith. In collab. with A. Berenstein Berlin u.a. Springer 1993 XVIII, 554 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Literaturverz. S. 467 - 540 Durchblutungsstörung (DE-588)4013340-0 gnd rswk-swf Gefäßkrankheit (DE-588)4071631-4 gnd rswk-swf Neuroophthalmologie (DE-588)4171592-5 gnd rswk-swf Augenkrankheit (DE-588)4112627-0 gnd rswk-swf Sehstörung (DE-588)4054284-1 gnd rswk-swf Neuroophthalmologie (DE-588)4171592-5 s Gefäßkrankheit (DE-588)4071631-4 s DE-604 Sehstörung (DE-588)4054284-1 s Durchblutungsstörung (DE-588)4013340-0 s Augenkrankheit (DE-588)4112627-0 s Berenstein, Alex 1947- Verfasser (DE-588)111120713 aut SWB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003673643&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Kupersmith, Mark J. Berenstein, Alex 1947- Neurovascular neuro-ophthalmology with 61 tables Durchblutungsstörung (DE-588)4013340-0 gnd Gefäßkrankheit (DE-588)4071631-4 gnd Neuroophthalmologie (DE-588)4171592-5 gnd Augenkrankheit (DE-588)4112627-0 gnd Sehstörung (DE-588)4054284-1 gnd |
| subject_GND | (DE-588)4013340-0 (DE-588)4071631-4 (DE-588)4171592-5 (DE-588)4112627-0 (DE-588)4054284-1 |
| title | Neurovascular neuro-ophthalmology with 61 tables |
| title_auth | Neurovascular neuro-ophthalmology with 61 tables |
| title_exact_search | Neurovascular neuro-ophthalmology with 61 tables |
| title_full | Neurovascular neuro-ophthalmology with 61 tables M. J. Kupersmith. In collab. with A. Berenstein |
| title_fullStr | Neurovascular neuro-ophthalmology with 61 tables M. J. Kupersmith. In collab. with A. Berenstein |
| title_full_unstemmed | Neurovascular neuro-ophthalmology with 61 tables M. J. Kupersmith. In collab. with A. Berenstein |
| title_short | Neurovascular neuro-ophthalmology |
| title_sort | neurovascular neuro ophthalmology with 61 tables |
| title_sub | with 61 tables |
| topic | Durchblutungsstörung (DE-588)4013340-0 gnd Gefäßkrankheit (DE-588)4071631-4 gnd Neuroophthalmologie (DE-588)4171592-5 gnd Augenkrankheit (DE-588)4112627-0 gnd Sehstörung (DE-588)4054284-1 gnd |
| topic_facet | Durchblutungsstörung Gefäßkrankheit Neuroophthalmologie Augenkrankheit Sehstörung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003673643&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT kupersmithmarkj neurovascularneuroophthalmologywith61tables AT berensteinalex neurovascularneuroophthalmologywith61tables |